BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15902827)

  • 1. Coronary thrombosis related to use of Xenadrine RFA.
    Sachdeva R; Sivasankaran S; Fishman RF; Zarich SW; McPherson CA
    Tex Heart Inst J; 2005; 32(1):74-7. PubMed ID: 15902827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary artery aneurysm and thrombosis following chronic ephedra use.
    Flanagan CM; Kaesberg JL; Mitchell ES; Ferguson MA; Haigney MC
    Int J Cardiol; 2010 Feb; 139(1):e11-3. PubMed ID: 18718687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasospasm and stroke attributable to ephedra-free xenadrine: case report.
    Holmes RO; Tavee J
    Mil Med; 2008 Jul; 173(7):708-10. PubMed ID: 18700609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literature.
    Thomas JE; Munir JA; McIntyre PZ; Ferguson MA
    Tex Heart Inst J; 2009; 36(6):586-90. PubMed ID: 20069086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More evidence supporting the ban of ephedra dietary supplements.
    Chavez ML
    Ann Pharmacother; 2004 May; 38(5):895-7. PubMed ID: 15044656
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.
    Shekelle PG; Hardy ML; Morton SC; Maglione M; Mojica WA; Suttorp MJ; Rhodes SL; Jungvig L; Gagné J
    JAMA; 2003 Mar; 289(12):1537-45. PubMed ID: 12672771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic effects of a dietary supplement containing ephedra and caffeine.
    Milic M; Rizos D; Ziegler MG
    JAMA; 2005 Sep; 294(12):1487; author reply 1487-8. PubMed ID: 16189358
    [No Abstract]   [Full Text] [Related]  

  • 8. Short-term metabolic and hemodynamic effects of ephedra and guarana combinations.
    Haller CA; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2005 Jun; 77(6):560-71. PubMed ID: 15961987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ephedra-associated cardiomyopathy.
    Naik SD; Freudenberger RS
    Ann Pharmacother; 2004 Mar; 38(3):400-3. PubMed ID: 14742827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ephedra banned.
    Cockey CD
    AWHONN Lifelines; 2004; 8(1):19-25. PubMed ID: 15031882
    [No Abstract]   [Full Text] [Related]  

  • 11. Working to get ephedra banned.
    Consum Rep; 2003 Feb; 68(2):6. PubMed ID: 12516584
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychiatric effects of ephedra use: an analysis of Food and Drug Administration reports of adverse events.
    Maglione M; Miotto K; Iguchi M; Jungvig L; Morton SC; Shekelle PG
    Am J Psychiatry; 2005 Jan; 162(1):189-91. PubMed ID: 15625222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ergogenic aids: an update on ephedra.
    Keisler BD; Hosey RG
    Curr Sports Med Rep; 2005 Aug; 4(4):231-5. PubMed ID: 16004835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial.
    McBride BF; Karapanos AK; Krudysz A; Kluger J; Coleman CI; White CM
    JAMA; 2004 Jan; 291(2):216-21. PubMed ID: 14722148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HHS to study ephedra, step up enforcement against illegal marketing.
    FDA Consum; 2002; 36(5):3. PubMed ID: 12412534
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular effects of ephedra.
    Ness J
    JAMA; 2004 Apr; 291(13):1560; author reply 1560-1. PubMed ID: 15069037
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular effects of ephedra.
    Krantz MJ
    JAMA; 2004 Apr; 291(13):1560; author reply 1560-1. PubMed ID: 15069036
    [No Abstract]   [Full Text] [Related]  

  • 18. JAMA patient page. Ephedra and ephedrine.
    Torpy JM; Lynm C; Glass RM
    JAMA; 2003 Mar; 289(12):1590. PubMed ID: 12672776
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychiatric symptoms associated with ephedra use.
    Maglione M; Miotto K; Iguchi M; Hilton L; Shekelle P
    Expert Opin Drug Saf; 2005 Sep; 4(5):879-84. PubMed ID: 16111450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relative safety of ephedra compared with other herbal products.
    Kalman DS; Antonio J; Kreider RB
    Ann Intern Med; 2003 Jun; 138(12):1006; author reply 1006-7. PubMed ID: 12809464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.